Oncobiolgics Inc

Cantor analysts, Mara Goldstein and Monica Gorman, believe that there existed Biosimilar play with potential for interchangeability in respect of Oncobiologics Inc (NASDAQ: ONSIU) shares. As a result, the two analysts have initiated the stock with a Buy Rating and kept a price tag of $15.00....